Drug interactions
Cenobamate + Paclitaxel
Severity: Moderate
Cenobamate and Paclitaxel: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Cenobamate induces CYP3A4 and may reduce paclitaxel concentrations, potentially weakening anticancer efficacy. The effect on paclitaxel is likely partial because CYP2C8 is also involved.
What this interaction means in plain words
Cenobamate and Paclitaxel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Cenobamate belongs to Central Nervous System; Paclitaxel belongs to Oncology.
Why it happens
Cenobamate induces CYP3A4, increasing paclitaxel metabolism.
What to do
Monitor tumour response and consider an alternative antiseizure drug without enzyme-inducing activity. Adjust paclitaxel only under oncology guidance.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cenobamate and Paclitaxel, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Paclitaxel
Other interactions of Cenobamate
Frequently asked questions
Can I take Cenobamate with Paclitaxel?
MediHelp rates the interaction as moderate. Cenobamate and Paclitaxel can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cenobamate induces CYP3A4 and may reduce paclitaxel concentrations, potentially weakening anticancer efficacy. The effect on paclitaxel is likely partial because CYP2C8 is also involved.
How serious is the interaction between Cenobamate and Paclitaxel?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor tumour response and consider an alternative antiseizure drug without enzyme-inducing activity. Adjust paclitaxel only under oncology guidance.
What other medicines interact with Paclitaxel?
MediHelp also lists interactions of Paclitaxel with, for example, Adenovirus types 4 and 7 live, Cobicistat, Cyclosporin. The full list is on the Paclitaxel page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.